Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a simple scan save kids from paralysis during tumor surgery?

NCT ID NCT06798532

Knowledge-focused Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looks back at medical records of 150 children who had surgery for neuroblastic tumors in the lower chest. Some had a special X-ray (arteriography) before surgery to map a key spinal artery, while others did not. Researchers want to see if the imaging helps prevent spinal cord damage after surgery. The goal is to find out whether this extra step is worth doing.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If this study finds that arteriography reduces complications, it could help standardize care and improve safety for children undergoing surgery for these tumors.
What could go wrong
This is a retrospective chart review, not a controlled trial, so it can only show associations, not prove cause and effect. The results may not change current practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 150 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2025

An estimate. Start dates often move.

Expected to finish

Apr 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients undergoing surgery for a neuroblastic tumor in a pediatric surgery department in France between 2005 and 2024 and meeting the inclusion criteria.

Ages

Up to 18 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Patients undergoing surgery for a neuroblastic tumor (neuroblastoma, ganglioneuroblastoma, ganglioneuroma) 2. Basithoracic location between T8 and L1 3. With or without intraspinal component 4. Treated in a pediatric surgery department in France 5. Between 2005 and 2024 6. Adult patients or holders of parental authority of minor patients informed and not opposed to the use of data for the study Exclusion Criteria: 1\. Post-operative follow-up of less than 6 months

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Ganglioneuroma are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

gangliocytoma ganglioneuroblastoma ganglioneuroma neoplasm neuroblastic tumor neuroblastoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Neuroblastic tumors Neuroblastoma Tumor, solid

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    27 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CHU Nantes

    Nantes, 44000, France

  • CHU Nice

    Nice, 06200, France

  • CHU d'Amiens

    Amiens, 80000, France

  • CHU de Besançon

    Besançon, 25000, France

  • CHU de Bordeaux

    Bordeaux, 33000, France

  • CHU de Brest

    Brest, 29200, France

  • CHU de Caen

    Caen, 14000, France

  • CHU de Dijon

    Dijon, 21079, France

  • CHU de Grenoble

    Grenoble, 38000, France

  • CHU de La Réunion

    Saint-Denis, 97405, France

  • CHU de Lille

    Lille, 59000, France

  • CHU de Limoges

    Limoges, 87000, France

  • CHU de Lyon

    Bron, 69677, France

  • CHU de Marseille

    Marseille, 13005, France

  • CHU de Montpellier

    Montpellier, 34090, France

  • CHU de Nancy

    Nancy, 54100, France

  • CHU de Poitiers

    Poitiers, 86000, France

  • CHU de Reims

    Reims, 51100, France

  • CHU de Rennes

    Rennes, 35203 CEDEX 2, France

  • CHU de Rouen

    Rouen, 76000, France

  • CHU de Strasbourg

    Strasbourg, 671091, France

  • CHU de Toulouse

    Toulouse, 31059 cedex 9, France

  • CHU de Tours

    Tours, 37000, France

  • Hôpital Bicêtre

    Le Kremlin-Bicêtre, 94270, France

  • Hôpital Necker enfants malades

    Paris, 75015, France

  • Hôpital Robert Debré

    Paris, 75019, France

  • Hôpital Trousseau

    Paris, 75012, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.